+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer



Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer



Cancer 115(5): 1059-1069



This study assessed the impact of surgical, histopathologic and patient-related factors on the risks of local and distant recurrence and overall survival for patients with stages I through IIIA nonsmall cell lung carcinoma (NSCLC) undergoing definitive resection with or without adjuvant chemotherapy. This study included 373 consecutive patients treated between 2000 and 2005 who did not receive adjuvant or neoadjuvant radiotherapy, had at least 3 months of follow-up, and did not have a history of other cancers within 5 years of the diagnosis of their NSCLC. Of these, 52% had pathologic stage IA disease, 30% had stage IB, 5% had stage IIA, 8% had stage IIB and 5% had stage III disease. Forty-four patients received chemotherapy. The median follow-up was 33 months. Local failure rates at 2 years, 3 years, and 5 years were 16%, 22%, and 32%, respectively; distant recurrence rates were 13%, 15%, and 21%, respectively. Multivariable analysis revealed that local recurrence was significantly associated with the presence of lymphatic or vascular invasion (LVI), the use of chemotherapy, and having diabetes; distant recurrence was significantly higher in patients with nonsquamous cell histology, those undergoing pneumonectomy, and those with more advanced TNM stage. Survival was significantly associated with age, history of myocardial infarction, performance of a pneumonectomy, histology, LVI, and the number of positive N1 lymph nodes. Local recurrence was the predominant type of failure in this series. Patient with diabetes or LVI may benefit from close surveillance and aggressive therapy of asymptomatic local recurrences, especially when chemotherapy is given in addition to surgery.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053193567

Download citation: RISBibTeXText

PMID: 19152440

DOI: 10.1002/cncr.24133


Related references

Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer. Cancer 116(10): 2390-2400, 2010

Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence. Journal of Clinical Oncology 26(15_Suppl): 7572-7572, 2016

Completely resected N1 nonsmall cell lung cancer: Factors affecting recurrence and long-term survival. Yearbook of Surgery 2007: 387-388, 2007

Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Annals of Surgery 235(1): 133-139, 2002

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 103(8): 1685-1692, 2005

Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 64(3): 192-196, 2009

Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. Journal of Thoracic Oncology 7(7): 1115-1123, 2012

Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer. Clinical Lung Cancer 17(5): E157-E167, 2016

Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 45(2): 262-267, 2014

Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 54(3): 554-559, 2018

Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients. Annals of Thoracic Surgery 81(3): 1021-1027, 2006

Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer. Lung Cancer International 2012: 463520, 2012

The role of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma: seeking to optimize local control and survival while minimizing toxicity. Cancer 86(2): 195-196, 1999

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Annals of Oncology 24(1): 67-74, 2013

Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 65(3): 241-245, 2010